B · Normal
[Novo Nordisk: New conditions for 48-hour delivery of semaglutide injection approved in China] Novo Nordisk announced on October 19 that China’s National Medical Products Administration (NMPA) has approved updating the product information of semaglutide injection (trade name: Novoin®): During distribution to patients, Novoin® can be stored at a temperature of 2°C–30°C for up to 48 hours before opening for the first time. According to Novo Nordisk, this approval makes Novoin® the first and only GLP-1 weight management treatment in China with this distribution flexibility.
Comments